Search Results

Topical Treatment of Actinic Keratoses with Piroxicam 1% Gel: A Preliminary Open-Label Study Utilizing a New Clinical Score

Authors: Campione, Elena; Diluvio, Laura; >Evelin Jasmine Paternò,; Chimenti, Sergio

Source: American Journal of Clinical Dermatology, Volume 11, Number 1, 1 February 2010 , pp. 45-50(6)

Publisher: Adis International

Effect of piroxicam administration before embryo transfer on IVF outcome: a randomized controlled trial

Authors: Dal Prato, Luca; Borini, Andrea

Source: Reproductive BioMedicine Online, Volume 19, Number 4, October 2009 , pp. 604-609(6)

Publisher: Reproductive Healthcare Ltd

Evaluation of proniosomes as an alternative strategy to optimize piroxicam transdermal delivery

Author: Alsarra, Ibrahim

Source: Journal of Microencapsulation, Volume 26, Number 3, May 2009 , pp. 272-278(7)

Publisher: Informa Healthcare

Photopatch testing with an extended series of photoallergens: a 5-year study

Authors: Cardoso, JoséCarlos; Canelas, Maria Miguel; Gonçalo, Margarida; Figueiredo, Américo

Source: Contact Dermatitis, Volume 60, Number 6, June 2009 , pp. 325-329(5)

Publisher: Blackwell Publishing

Carboxymethyl Mungbean Starch as a New Pharmaceutical Gelling Agent for Topical Preparation

Authors: Kittipongpatana, Ornanong; Burapadaja, Siriporn; Kittipongpatana, Nisit

Source: Drug Development and Industrial Pharmacy, Volume 35, Number 1, January 2009 , pp. 34-42(9)

Publisher: Informa Healthcare

Effect of piroxicam gel for pain control and inflammation in Nd:YAG 1064-nm laser hair removal

Authors: Akinturk, S; Eroglu, A

Source: Journal of the European Academy of Dermatology & Venereology, Volume 21, Number 3, March 2007 , pp. 380-383(4)

Publisher: Blackwell Publishing

In vitro effects of some drugs on catalase purified from human skin

Authors: Altikat, Sayit; Coban, Abdulkadir; Ciftci, Mehmet; Ozdemir, Hasan

Source: Journal of Enzyme Inhibition and Medicinal Chemistry, Volume 21, Number 2, April 2006 , pp. 231-234(4)

Publisher: Informa Healthcare

Rheological analysis of the structural properties effecting the percutaneous absorption and stability in pharmaceutical organogels

Authors: Pénzes, Tímea; Csóka, Ildikó; Erős, István

Source: Rheologica Acta, Volume 43, Number 5, November 2004 , pp. 457-463(7)

Publisher: Springer

PLG Microsphere Size Controls Drug Release Rate Through Several Competing Factors

Authors: Berkland C.; Kim K..; Pack D.W.

Source: Pharmaceutical Research, Volume 20, Number 7, July 2003 , pp. 1055-1062(8)

Publisher: Springer

Determination of piroxicam by solid-phase spectrophotometry in a continuous flow system

Authors: Pascual-Reguera M.I.; Ayora-Canada M.J.; Castro Ruiz M.S.

Source: European Journal of Pharmaceutical Sciences, Volume 15, Number 2, March 2002 , pp. 179-183(5)

Publisher: Elsevier

Sensitive LC determination of piroxicam after in vitro transdermal permeation studies

Authors: Doliwa A.; Santoyo S.; Campanero M.A.; Ygartua P.

Source: Journal of Pharmaceutical and Biomedical Analysis, Volume 26, Number 4, November 2001 , pp. 531-537(7)

Publisher: Elsevier

Piroxicam delivery into human stratum corneum in vivo: iontophoresis versus passive diffusion

Authors: Curdy C.; Kalia Y.N.; Naik A.; Guy R.H.

Source: Journal of Controlled Release, Volume 76, Number 1, 11 September 2001 , pp. 73-79(7)

Publisher: Elsevier

Effects of non-ionic surfactants as permeation enhancers towards piroxicam from the poloxamer gel through rat skins

Authors: Shin S.-C.; Cho C.-W.; Oh I.-J.

Source: International Journal of Pharmaceutics, Volume 222, Number 2, 17 July 2001 , pp. 199-203(5)

Publisher: Elsevier

Inclusion complex of piroxicam with -cyclodextrin and incorporation in cationic microemulsion. In vitro drug release and in vivo topical anti-inflammatory effect

Authors: Dalmora M.E.; Dalmora S.L.; Oliveira A.G.

Source: International Journal of Pharmaceutics, Volume 222, Number 1, 3 July 2001 , pp. 45-55(11)

Publisher: Elsevier

Effect of skin pretreatment with fatty acids on percutaneous absorption and skin retention of piroxicam after its topical application

Authors: Santoyo S.; Ygartua P.

Source: European Journal of Pharmaceutics and Biopharmaceutics, Volume 50, Number 2, September 2000 , pp. 245-250(6)

Publisher: Elsevier

A randomized controlled trial comparing topical piroxicam gel with a homeopathic gel in osteoarthritis of the knee

Authors: van Haselen R.A.; Fisher P.A.G.

Source: Rheumatology, Volume 39, Number 7, July 2000 , pp. 714-719(6)

Publisher: Oxford University Press

Stability indicating HPTLC determination of piroxicam

Authors: Puthli S.P.; Vavia P.R.

Source: Journal of Pharmaceutical and Biomedical Analysis, Volume 22, Number 4, May 2000 , pp. 673-677(5)

Publisher: Elsevier

Enhanced efficacy by percutaneous absorption of piroxicam from the poloxamer gel in rats

Authors: Shin S.-C.; Cho C.-W.; Oh I.-J.

Source: International Journal of Pharmaceutics, Volume 193, Number 2, 5 January 2000 , pp. 213-218(6)

Publisher: Elsevier

The influence of the physicochemical characteristics and pharmacokinetic properties of selected NSAID's on their transdermal absorption

Authors: Beetge E.; du Plessis J.; Muller D.G.; Goosen C.; van Rensburg F.J.

Source: International Journal of Pharmaceutics, Volume 193, Number 2, 5 January 2000 , pp. 261-264(4)

Publisher: Elsevier

High-performance liquid chromatographic determination with amperometric detection of piroxicam in human plasma and tissues

Authors: de Jager A.D.; Ellis H.; Hundt H.K.L.; Swart K.J.; Hundt A.F.

Source: Journal of Chromatography B: Biomedical Sciences and Applications, Volume 729, Number 1, 11 June 1999 , pp. 183-189(7)

Publisher: Elsevier